LGALS3 and type 2 diabetes mellitus: The results of galectin-3 in T2DM seems confusing because some studies claim that galectin-3 deficiency is associated with insulin resistance, and galectin-3 elicits a protective effect in T2DM by acting as a receptor for advanced glycation end products (AGEs) [32,33].